NKG2D-expressing immune cells are decreased in patients with cervical cancer and precursor lesions by Naela A Arreygue-Garcia (43801)

mTORC1 hyperactivation led to a decreased autophagic activity in the podocytes. by Wakiko Iwata (8600457)

“…<p>(<b>A</b>) Primary cultured podocytes were isolated from <i>Tsc2</i>^{Δ<i>podocyte</i>} and wild-type controls, followed by western blot analyses of TSC2, phospho-4EBP1, LC3B type II, p62, phospho-ULK1, and β-tubulin. …”

<i>crh-1</i> mutants exhibit a decrease of <i>daf-7</i> expression in the ASI neurons. by JiSoo Park (11133976)

Ethanol withdrawal (EW) decreases GluN2A subunit levels. by Marina Rubio (345805)

Knockdown of Ube2d proteins decreases ubiquitination of EGFR in HeLa cells. by Mariya S. Liyasova (3821908)

NAC decreases the effect of rhSP-D on viability and intracellular oxidative burst in AML14.3D10 cells. by Lakshna Mahajan (504239)

Inhibition of the mitochondrial fission decreases mtROS production. by Dong Ma (584680)

Derlin-2 overexpression decreases proinsulin steady state levels. by Hanneke Hoelen (359284)

Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

“…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”

TMEM16A knockdown induced a decrease in proliferation of SW620 cells. by Yujie Sui (549090)

Tunicamycin-induced ER stress decreases epithelial barrier integrity in Caco-2 monolayers by plasma membrane disruption. by Takuya Akiyama (652368)

An ATR-specific inhibitor decreases HBoV1 infection of HAE-ALI. by Xuefeng Deng (138723)

An ATM-specific inhibitor decreases HBoV1 infection of HAE-ALI. by Xuefeng Deng (138723)

The large decrease in R but small decrease of O₂ across the night. by Matthew H. Long (387725)

“…Figure C and D show a 5 to 15% decrease in the O₂ concentration across the night which cannot explain the decrease in respiration. …”

Cell nuclear volume decreases under increasing osmotic pressure. by Adele Khavari (7378082)

Myelinated axon density is decreased in the Rictor CKO. by Mark D. Grier (726986)

TMEM182 decreases OSCC cell motility. by En-Wei Hsing (154990)

Gefitinib and erlotinib decreased cyclin-D1 without activation of caspase-3. by Satoshi Koyama (784927)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…<b>(B)</b> VRK1 protein expression is higher in the vast majority of lymph node metastases (24 of 28) than in patient-matched primary tumors. <b>(C)</b> <a href="http://Oncomine.org" target="_blank">Oncomine.org</a> was used to probe the complete Curtis Breast dataset (2,136 samples) in order to determine whether the VRK1 mRNA was within the top 10% of overexpressed transcripts in breast cancer samples vs. normal breast tissue. …”